CEBPA and hepatocellular carcinoma: There is growing evidence suggesting that lipid metabolism plays a critical role in HCC pathogenesis, key enzymes in certain lipid metabolic pathways, such as CCAAT/enhancer binding protein α (CEBPA) [2] and carnitine palmitoyltransferase 1 (CPT1) [3], are implicated in HCC by modulating lipid synthesis and oxidation, processes essential for tumor growth and survival.